Nano-Bubble Hydrogen Water in Wet-Wrap Dressing Improves the Severity of Pediatric Patients With Atopic Dermatitis.
Lai-San Wong, Ho-Chang Kuo · Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 20 patients, hW wet-wrap significantly reduced erythema (0.5 ± 0.69, p =.01), dryness (0.7 ± 0.57, p =.002), and total score (1.55 ± 1.64, p <.0001), while pure water showed no significant changes. These findings add human evidence supporting molecular hydrogen's therapeutic potential for Alzheimer's disease.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in 20 patients. HW wet-wrap significantly reduced erythema (0.5 ± 0.69, p =.01), dryness (0.7 ± 0.57, p =.002), and total score (1.55 ± 1.64, p <.0001), while pure water showed no significant changes.
What the Researchers Studied
The researchers studied 20 patients. The study used a human clinical study.
What Effects Did Molecular Hydrogen Have?
HW wet-wrap significantly reduced erythema (0.5 ± 0.69, p =.01), dryness (0.7 ± 0.57, p =.002), and total score (1.55 ± 1.64, p <.0001), while pure water showed no significant changes. The authors concluded that hW wet-wrap therapy is a safe, effective adjunct for pediatric AD, improving erythema, dryness, and hydration while limiting systemic side effects.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential for Alzheimer's disease and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 20 patients. The reported sample size was 8. The study used a human clinical study.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.